Načítá se...
Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol?
Although upfront surgery has been the gold standard for pancreatic adenocarcinoma that is planned for resection, it should be compared with the alternative strategy of neoadjuvant therapy. Despite the many reports of the efficacy of neoadjuvant therapy, most of them were not comparative. Recently Pr...
Uloženo v:
| Vydáno v: | Ann Gastroenterol Surg |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7105839/ https://ncbi.nlm.nih.gov/pubmed/32258974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12311 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|